Have a personal or library account? Click to login
Outcomes of Vaccination Against SARS-CoV-2 in Patients with Rheumatic Diseases in Latvia Cover

Outcomes of Vaccination Against SARS-CoV-2 in Patients with Rheumatic Diseases in Latvia

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
Volume 78 (2024): Issue 1 (February 2024)
By: Inita Buliņa and  Jūlija Zepa  
Open Access
|Mar 2024

Authors

Inita Buliņa

inita.bulina@stradini.lv

Centre of Rheumatology, Pauls Stradiņš Clinical University Hospital, Rīga, Latvia
Internal Diseases Department, Rīga Stradiņš University, Rīga, Latvia
Faculty of Medicine, University of Latvia, Rīga, Latvia

Jūlija Zepa

Centre of Rheumatology, Pauls Stradiņš Clinical University Hospital, Rīga, Latvia
Internal Diseases Department, Rīga Stradiņš University, Rīga, Latvia
DOI: https://doi.org/10.2478/prolas-2024-0004 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Journal RSS Feed
Language: English
Page range: 22 - 28
Submitted on: Oct 4, 2022
|
Accepted on: Jan 12, 2024
|
Published on: Mar 4, 2024
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
arthritis,
rare diseases,
vaccination against COVID-19,
comorbidities
Related subjects:
General interest,
Mathematics,
General mathematics

© 2024 Inita Buliņa, Jūlija Zepa, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 78 (2024): Issue 1 (February 2024)Next article